Completed NA INTERVENTIONAL 2-arm
NCT06833996
The Efficacy of Bakuchiol in Treating PIH
The Efficacy of Bakuchiol in Treating Post-inflammatory Hyperpigmentation
Sponsor: Henry Ford Health System
Conditions
Post Inflammatory Hyperpigmentation
Updated 1 time since 2025 Last updated: Feb 13, 2025 Started: Feb 22, 2016 Primary completion: May 23, 2018 Completion: May 5, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06833996, this NA trial focuses on Post Inflammatory Hyperpigmentation and remains completed. Sponsored by Henry Ford Health System, it has been updated 1 time since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Henry Ford Health System
Data source: Henry Ford Health System
For direct contact, visit the study record on ClinicalTrials.gov .